Synthesis of the highly potent prostanoid FP receptor agonist, AFP-168: a novel 15-deoxy-15,15-difluoroprostaglandin F 2α derivative
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Tetrahedron Letters
- Vol. 45 (7) , 1527-1529
- https://doi.org/10.1016/j.tetlet.2003.12.029
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- New Fluoroprostaglandin F2.ALPHA. Derivatives with Prostanoid FP-Receptor Agonistic Activity as Potent Ocular-Hypotensive AgentsBiological & Pharmaceutical Bulletin, 2003
- Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAmerican Journal of Ophthalmology, 2001
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001
- Synthesis of Novel Difluoroprostacyclin Derivatives: Unprecedented Stabilizing Effect of Fluorine SubstituentsAngewandte Chemie International Edition in English, 1996
- Novel Fluoroprostacyclin Analogs with Modified Cycloalkylenyl Chains. Highly Potent and Orally Active Anti-anginal Agents.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Synthesis of therapeutically useful prostaglandin and prostacyclin analogsChemical Reviews, 1993
- N-(Methanesulfonyl)-16-phenoxyprostaglandin carboxamides: tissue-selective, uterine stimulantsJournal of Medicinal Chemistry, 1981
- Total synthesis of 15-methylprostaglandinsJournal of the American Chemical Society, 1974
- New reagents for stereoselective carbonyl reduction. Improved synthetic route to the primary prostaglandinsJournal of the American Chemical Society, 1971
- 9α-FLUORO DERIVATIVES OF CORTISONE AND HYDROCORTISONEJournal of the American Chemical Society, 1954